A New International Congress on Regenerative Medicine Held With Great Success by Cryo-Save in Bosnia

Zutphen, The Netherlands (ots/PRNewswire) -

It is part of Cryo-Save's educational program deployment to
increase the awareness of stem cells therapy and regenerative
medicine amongst healthcare professionals.

The Second international congress "Regenerative medicine - stem
cells, genetic engineering and biotechnology" was held on December 9
in Sarajevo, supported by the Institute for Genetic Engineering and
Biotechnology and Cryo-Save, Europe's leading stem cell bank with
their local partner, FAMILY-PLUS.

After the recent initiatives in Serbia and Italy, the Bosnian
Congress joins Cryo-Save's official training plans and reaffirms the
efforts of the company to put together its educational program about
stem cells therapies and current applications.

Arnoud van Tulder, CEO of Cryo-Save Group, addressed to
participants that Cryo-Save is fully committed in creating a new
approach towards stem cells storage, with the aim to increase global
awareness about current treatments and future promising applications.
"We are aware of our leading role and therefore we have created and
supported different educational programs which should help doctors
and scientists to offer latest news from current researches about use
of stem cells. Our know-how directly derives from our experience: in
over ten years of activity, we have over 200.000 samples stored", van
Tulder said.

With participation of local doctors, the congress also welcomed
eminent names of world medicine, primarily those who regularly
implement stem cell treatments in their practice.

Dr. Zoran Gali?, from UCLA University in Los Angeles, referred
that "field of stem cells presents one of the most dynamic research
disciplines of modern medicine and points out large number of
potential therapies based on these cells."

Prof. Christof Stamm, from German Heart Institute Berlin (DHZB) -
Cardiac, thoracic and vascular surgery, said that research work in
the field of cardiovascular regenerative medicine raises hope.
"Research on the treatment of heart muscle tissue with stem cells
from bone marrow have created strong basis for clinical and
experimental studies. For decades it's been known that cord blood
contains hematopoietic stem cells. One of main reasons for their use
is their young age and their potential to differentiate easily into
certain types of adult cells," said prof. Stamm.

Cherie Daly, MD, member of ITERA and member of Medical Advisory
Board of Parents Guide to Cord Blood Foundation, referred to the
history of umbilical cord blood transplants. The past 23 years of
cord blood stem cells transplantations showed that cord blood can
successfully be preserved without losses in vitality and
functionality; it is an efficient source of stem cells to treat a
large number of diseases, including malignant hematological diseases,
bone marrow, hemoglobinepathies and inborn errors of metabolism.

Cryo-Save: http://www.cryo-save.com/group

Cryo-Save, the leading international family stem cell bank, stores
more than 200,000 samples from umbilical cord blood, cord tissue and
adipose tissue. There are already many diseases treatable by the use
of stem cells, and the number of treatments will only increase.
Driven by its international business strategy, Cryo-Save is now
represented in over 40 countries on four continents, with
ultra-modern processing and storage facilities in the United States,
Belgium, Germany, Dubai, India, South Africa and France (validation
in progress).

Rückfragehinweis:
More information: Cécile Kastler: cecile.kastler@cryo-save.com -
tel. +41-55-222-0251

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | PRN

print